Get started
FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNOFUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNOFUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

No trades
See on Supercharts
Overview
Analysis
Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪1.60 B‬ TWD
Fund flows (1Y)
‪−609.47 M‬ TWD
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.1%
Shares outstanding
‪206.51 M‬
Expense ratio
1.05%

About FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO


Issuer
Fubon Financial Holding Co., Ltd.
Brand
Fubon
Home page
websys.fsit.com.tw
Inception date
Oct 4, 2021
Structure
Open-Ended Fund
Index tracked
NYSE FactSet Global Genomics and Immuno Biopharma Index
Replication method
Physical
Management style
Passive
Distributes
Capital Gains
Primary advisor
Fubon Asset Management Co., Ltd.
ISIN
TW0000089705
Fubon NYSE FactSet Global Genomics and Immuno Biopharma Exchange Traded Fund seeks investment results that closely track the performance of NYSE FactSet Global Genomics and Immuno Biopharma Index, before fees and expenses

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of January 22, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks97.67%
Health Technology96.52%
Health Services0.68%
Commercial Services0.45%
Bonds, Cash & Other2.33%
Futures2.35%
Cash−0.02%
Stock breakdown by region
66%22%10%
North America66.84%
Europe22.85%
Asia10.30%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows